方盛制药：关于控股子公司获得《药品生产许可证》的公告

Group 1 - The company Fangsheng Pharmaceutical announced that its subsidiary GuangDong Fangsheng Ronghua Pharmaceutical Co., Ltd. has received a Drug Production License from the Guangdong Provincial Drug Administration [2] - The license allows the subsidiary to act as the marketing authorization holder for the production of Riluzole tablets, with a validity period until January 26, 2031 [2]